Chemotherapy induced peripheral neuropathy. Other disorders of peripheral nervous system
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Age 35 to 60 years Both genders male and female Willing to participate in research Cancer patients of stage ?-? Receiving neurotoxic drugs (platinum based, taxanes based or both in combination) Have received at least 4 cycles of chemotherapy treatment Having numbness and tingling in distal areas Pain in distal areas At medium (19-24) to high (<19) risk of fall according to POMA Able to communicate in Punjabi/Urdu/English
Exclusion criteria
Exclusion criteria: Cognitive dysfunction (Mini-Mental State exam score?24) Any recent major surgery Having diabetic neuropathy before getting chemotherapy drugs Unhealed lower extremity fracture Other neurological problems including brain cancer Cardiovascular diseases Bone metastasis Lower limb lymphedema Musculoskeletal problems Amputated limb With abnormal visual or auditory senses Uncooperative patients
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain. Timepoint: Before treatment and at the end of 4 weeks of intervention. Method of measurement: Numerical pain rating scale(NPRS) was used.;Balance. Timepoint: Before the treatment and at the end of 4 weeks of intervention. Method of measurement: Performance oriented mobility assessment (POMA).;Gait. Timepoint: Before the treatment and at the end of 4 weeks of intervention. Method of measurement: Timed up and go test(TUG), F8WT(figure of 8 walk test). | — |
Countries
Pakistan
Contacts
The University of Faisalabad